News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Management Changes At Ecopia BioSciences Inc. (EIA.TO)



10/23/2006 10:45:37 AM

MONTREAL, QUEBEC -- (MARKET WIRE) -- October 20, 2006 -- Ecopia BioSciences Inc. (TSX: EIA) announced today a series of management changes. Mr. Gregory L. White, who joined Ecopia in September 2004 to implement and manage the drug development aspects of the Company, has been appointed Vice-President, Operations. In addition to continuing to oversee the development of our lead compound, ECO-4601, Mr. White will play a key role in business development and strategic alliances activities. Dr Jim McAlpine, Vice-President, Chemistry and Discovery, who was instrumental in the discovery and pre-clinical development of Ecopia's New Chemical Entities, including ECO-4601, will assume direct responsibility of the discovery-related activities including the ECO-4601's analog program, which we believe will lead to our second oncology drug candidate. Dr Emmanuel Zazopoulos, Vice-president, Operations, Drug Discoveries has left the Company to take on new challenges.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES